| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |